Literature DB >> 18195236

Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.

Paul M Phillips1, Steven A Newman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18195236     DOI： 10.1001/archophthalmol.2007.17

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  3 in total

Review 1.  Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.

Authors:  Obi C Umunakwe; David Herren; Stephen J Kim; Sahar Kohanim
Journal:  Digit J Ophthalmol       Date:  2017-12-28

2.  Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  F Procianoy; E Procianoy
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

Review 3.  Orbital Inflammation Caused by Aminobisphosphonates.

Authors:  J Gonzalez Barlatay; C Pagano Boza; G V Hernandez Gauna; J E Premoli
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.